Fighting Covid: Govt mulling to discontinue Azithromycin on critical patients

The Ministry of Health and Family Welfare is likely to withdraw the use of Azithromycin, which was being administered to severely ill COVID-19 patients in the intensive care units (ICUs), from the combination of Azithromycin and Hydroxychloroquine (HCQ).

The Ministry of Health and Family Welfare is likely to withdraw the use of Azithromycin, which was being administered to severely ill COVID-19 patients in the intensive care units (ICUs), from the combination of Azithromycin and Hydroxychloroquine (HCQ). According to a government official, the use of Azithromycin was not "much beneficial" on coronavirus patients.

However, the antiviral drug HCQ will be used both on moderate and severe COVID-19 patients. The Union Health Ministry is likely to amend the existing COVID-19 clinical management guidelines issued by the central government. (ANI)